Trial Profile
An Open-label, Randomized, Parallel Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary) ; Tamsulosin (Primary)
- Indications Lower urinary tract symptoms; Overactive bladder
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 29 Mar 2016 New trial record